Sort
50,496 grants matching “lung cancer”
Vanderbilt-Emory-Cornell-Duke Consortium for Global Health Fellows (VECDor)
$821,645Douglas C Heimburger · Vanderbilt University Medical Center · R25 · FY2016 · TW
Vascular, Pulmonary and Renal Injury
$821,426Richard N Mitchell · Brigham And Women'S Hospital · T32 · FY2017 · HL
Molecular Pathology of Pulmonary Carcinogenesis
$821,289Ilona Linnoila · Division Of Clinical Sciences - Nci · Z01 · FY2008 · CA
Biological Fluid Dynamics in Morphogenesis
$821,273Sharon R Lubkin · North Carolina State University · · FY2002 · MPS
Non-Invasive Diagnosis of Pediatric Pulmonary Invasive Mold Infections
$820,854William J Steinbach · Duke University · R01 · FY2018 · AI
Prevalence of environmental and genetic risk factors for gastric cancer in a popu
$820,851Lovell Allan Jones · University Of Tx Md Anderson Can Ctr · P60 · FY2009 · MD
Computational and Experimental RNA Nanobiology
$820,772Bruce Shapiro · Division Of Basic Sciences - Nci · ZIA · FY2014 · CA
Interstitial Lung Abnormalities: Defining the Phenotype, Causes, and Consequences.
$820,729Gary Matthew Hunninghake · Brigham And Women'S Hospital · R01 · FY2022 · HL
ARKANSAS SPECIAL POPULATIONS ACCESS NETWORK (A-SPAN)
$820,491University Of Arkansas Med Scis Ltl Rock · U01 · FY2002 · CA
Immunotherapy for Malignant Mesothelioma, Lung Cancer and Thymic Malignancies
$820,478Raffit Hassan · Division Of Basic Sciences - Nci · ZIA · FY2018 · CA
3/3 Florida-California Cancer Research, Education and Engagement (CaRE2) Health Equity Center
$820,069Mariana C Stern · University Of Southern California · U54 · FY2024 · CA
Integration of Biomarker Signatures from Peripheral Blood for Diagnosis, Prognosis, Remission and Recurrence of Lung Cancer
$819,590Louise C Showe · Wistar Institute · U01 · FY2019 · CA
Risk Stratification for COPD Exacerbations with CT Analysis and Multidimensional Trajectory Subtyping
$819,313James Ross · Brigham And Women'S Hospital · R01 · FY2025 · HL
Assistive ExoSkeleton and ExoTendon System for Increased Return of Limb Function after Diabetic Foot Ulcer
$819,135Mark C Roser · Results Group · R44 · FY2022 · NR
New Roles of Magnesium as a Regulatory Ion in Immune Responses and Cell Behavior
$818,915Michael J Lenardo · National Institute Of Allergy And Infectious Diseases · ZIA · FY2019 · AI
MOUNT SINAI COMMUNITY CLINICAL ONCOLOGY PROGRAM
$818,903Mount Sinai Medical Center (Miami Beach) · U10 · FY2004 · CA
Clinical Implications, Genomics, and Transcriptions of Mucus Plugging in Smokers
$818,818Alejandro Diaz · Brigham And Women'S Hospital · R01 · FY2021 · HL
Clinical Implications, Genomics, and Transcriptions of Mucus Plugging in Smokers
$818,818Alejandro Diaz · Brigham And Women'S Hospital · R01 · FY2023 · HL
Clinical Implications, Genomics, and Transcriptions of Mucus Plugging in Smokers
$818,818Alejandro Diaz · Brigham And Women'S Hospital · R01 · FY2022 · HL
Autologous Lung Multipotent Stromal Cell Therapy for Emphysema
$818,761Edward P Ingenito · Brigham And Women'S Hospital · R01 · FY2014 · HL
A randomized trial of cardioprotective strategies in newly diagnosed diffuse large B-cell lymphoma and pre-existing cardiomyopathy or prior anthracycline exposure
$818,625Jenica Upshaw · Beth Israel Deaconess Medical Center · R37 · FY2025 · CA
The Role of Wnt Genes in Vertebrate Development and Cancer
$818,443Terence Yamaguchi · Division Of Basic Sciences - Nci · ZIA · FY2009 · CA
Pro-apoptotic Drugs as Host-Directed Treatments for Pulmonary Tuberculosis
$817,941Sanjay Jain · Johns Hopkins University · R56 · FY2024 · AI
Epidemiology of Venous Thrombosis and Pulmonary Embolism
$817,909Aaron R Folsom · University Of Minnesota · R01 · FY2021 · HL
Systematic identification of oncogenic KRAS synthetic lethal interactions
$817,805William C Hahn · Broad Institute, Inc. · U01 · FY2015 · CA